Caladrius Biosciences Inc (NASDAQ:CLBS)

0.9445
Delayed Data
As of Nov 29
 -0.0355 / -3.62%
Today’s Change
0.92
Today|||52-Week Range
4.89
-33.95%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Caladrius Biosciences Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +852.89% increase from the last price of 0.94.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Caladrius Biosciences Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.15
Sales
$0.00
Reporting Date
Mar 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.00%
 
 
 
 
 
Growthannually -3.77%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.